XVIVO delivered an organic growth surprise at 32% (CER, 32% in Q1) during Q2 a quarter, with a subst...
Ahead of the Fiskars Q2, due on 18 July, we maintain our estimates intact.
- Q2e: Slight margin improvements expected - Org. estimates mostly unchanged, EBITA down 2-3% on FX ...
Redeye provides an update following Iconovo’s Q2 report.
Redeye makes negligible estimate revisions on the back of Climeon’s Q2 figures which was in line wit...
Redeye updates its estimates and valuation following Lifco releasing its Q2 2024 report.
Atria raised its guidance on 12 July. The company now expects its adjusted EBIT to improve from 2023...
Redeye reduces its Base Case slightly despite cutting its 2024-2025 EBIT forecasts following a mixed...
- Q2: stable top line despite headwinds, margins keep improving y-o-y - Tweaked '24e, as we look for...
- Q2 sales SEK 54m, EBIT SEK -1.0m, vs. ABGSCe 52m and -1.
Atria raised its adjusted EBIT guidance and now expects growing earnings in 2024 (earlier: adjusted ...
- Q2: Gross margin lead the way to a 9% adj. EBITA beat vs cons - Positive comments on demand across...
- Q2 sales a touch above our ests. at SEK 229m, for 7% org.
- Adj. EBITA of SEK 161m (0% vs ABGSC, -3% vs cons) - Est's down 2-3% on lower effects of cost savin...
Redeye comments on Climeon’s Q2 figures being without any material income in the quarter, which was ...
Redeye comments on Carasent’s Q2 2024 report, which came in slightly lower on revenues.
Redeye sees a solid Q2 report from Fortnox, with strong net customer intake and high growth in Core ...
Redeye sees an overall solid report, with the rebound in ACV being the highlight.
- Adj. EBITA SEK 215m (-3% vs. ABGSCe 222m) - Consensus full-year EBITA likely down marginally - 12x...
- Q2: Adj. EBITDA of NOK 1m vs. our NOK -2m - New targets more achievable with Sainsbury's and Merca...
